NK4 or adenovirus vector expressing NK4 (Ad-NK4) can act bifunctionally as a hepatocyte growth factor antagonist and angiogenesis inhibitor and has potential value in cancer therapy. The aim of this ...
The use of performance-enhancing drugs in sports is commonly referred by the term ‘doping’, particularly by those regulatory bodies overseeing sports that have made efforts to fight doping. Through ...
New York [USA], Jan 1 (ANI): Mastering the targeted delivery of therapeutic genes to the desired location within the body is the first necessary step towards implementing gene therapy to treat renal ...
A detailed analysis of von Hippel Lindau (VHL) mutations in sporadic clear cell renal carcinoma (ccRCC), VHL syndrome, and Chuvash polycythaemia. Background: GLIPR1/RTVP-1 is up-regulated by p53 in ...
CHICAGO--(BUSINESS WIRE)--Gene delivery technologies are turning into the next big-ticket item globally, as the most recent investment received by VectorBuilder Inc., a global leader in this field, ...
New Rochelle, NY, August 13, 2018--A new study has shown that a single injection of a novel adeno-associated vector (AAV)-based therapy can result in improved enzyme activ-ity and glycogen clearance ...
A subcutaneous injection, or shot, enters the fatty tissues just beneath the skin. It is shallower than an injection into muscle tissue. Healthcare professionals often use subcutaneous injections for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback